206 related articles for article (PubMed ID: 3141284)
21. Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.
Speert DP; Eftekhar F; Puterman ML
Infect Immun; 1984 Mar; 43(3):1006-11. PubMed ID: 6421734
[TBL] [Abstract][Full Text] [Related]
22. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis.
Pier GB; Coleman F; Grout M; Franklin M; Ohman DE
Infect Immun; 2001 Mar; 69(3):1895-901. PubMed ID: 11179370
[TBL] [Abstract][Full Text] [Related]
23. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. II. Induction of heterologous immunity by mucoid strains of P. aeruginosa.
Gościniak G; Grzybek-Hryncewicz K
Arch Immunol Ther Exp (Warsz); 1988; 36(2):185-93. PubMed ID: 3149177
[TBL] [Abstract][Full Text] [Related]
24. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
Hatano K; Goldberg JB; Pier GB
Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730
[TBL] [Abstract][Full Text] [Related]
25. Aeration selects for mucoid phenotype of Pseudomonas aeruginosa.
Krieg DP; Bass JA; Mattingly SJ
J Clin Microbiol; 1986 Dec; 24(6):986-90. PubMed ID: 3097070
[TBL] [Abstract][Full Text] [Related]
26. Glucose stimulates phagocytosis of unopsonized Pseudomonas aeruginosa by cultivated human alveolar macrophages.
Wong SY; Guerdoud LM; Cantin A; Speert DP
Infect Immun; 1999 Jan; 67(1):16-21. PubMed ID: 9864190
[TBL] [Abstract][Full Text] [Related]
27. Psl Produced by Mucoid
Jones CJ; Wozniak DJ
mBio; 2017 Jun; 8(3):. PubMed ID: 28634241
[TBL] [Abstract][Full Text] [Related]
28. Correlation of serum opsonic activity in cystic fibrosis with colonization and disease state: measurement of opsonins to Pseudomonas aeruginosa by neutrophil superoxide anion generation.
Bender JG; Florman AL; Van Epps DE
Pediatr Res; 1987 Oct; 22(4):383-8. PubMed ID: 2825106
[TBL] [Abstract][Full Text] [Related]
29. Colonial dissociation and susceptibility to phagocytosis of Pseudomonas aeruginosa grown in a chamber implant model in mice.
Kelly NM; Battershill JL; Kuo S; Arbuthnott JP; Hancock RE
Infect Immun; 1987 Nov; 55(11):2841-3. PubMed ID: 3117694
[TBL] [Abstract][Full Text] [Related]
30. Oxidative response of human neutrophils, monocytes, and alveolar macrophages induced by unopsonized surface-adherent Staphylococcus aureus.
Devalon ML; Elliott GR; Regelmann WE
Infect Immun; 1987 Oct; 55(10):2398-403. PubMed ID: 2820882
[TBL] [Abstract][Full Text] [Related]
31. Phagocytosis of unopsonized Pseudomonas aeruginosa by murine macrophages is a two-step process requiring glucose.
Speert DP; Gordon S
J Clin Invest; 1992 Sep; 90(3):1085-92. PubMed ID: 1522217
[TBL] [Abstract][Full Text] [Related]
32. Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients.
Pier GB; Desjardins D; Aguilar T; Barnard M; Speert DP
J Clin Microbiol; 1986 Aug; 24(2):189-96. PubMed ID: 2943759
[TBL] [Abstract][Full Text] [Related]
33. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. III. Polyvalent serum against three mucoid immunotypes potentiates phagocytosis of all (7) mucoid immunotypes.
Gościniak G; Grzybek-Hryncewicz K
Arch Immunol Ther Exp (Warsz); 1988; 36(2):195-203. PubMed ID: 3149178
[TBL] [Abstract][Full Text] [Related]
34. Alginate--its role in neutrophil responses and signal transduction towards mucoid Pseudomonas aeruginosa bacteria.
König B; Friedl P; Pedersen SS; König W
Int Arch Allergy Immunol; 1992; 99(1):98-106. PubMed ID: 1336422
[TBL] [Abstract][Full Text] [Related]
35. Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells.
Ramphal R; Pier GB
Infect Immun; 1985 Jan; 47(1):1-4. PubMed ID: 3155514
[TBL] [Abstract][Full Text] [Related]
36. Pneumocystis carinii induces an oxidative burst in alveolar macrophages.
Hidalgo HA; Helmke RJ; German VF; Mangos JA
Infect Immun; 1992 Jan; 60(1):1-7. PubMed ID: 1729174
[TBL] [Abstract][Full Text] [Related]
37. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
[TBL] [Abstract][Full Text] [Related]
39. Phagocytosis and intracellular killing of mucoid and nonmucoid variants of Pseudomonas aeruginosa by polymorphonuclear leukocytes: effect of specific immune sera.
Gościniak G; Maresz-Babczyszyn J; Grzybek-Hryncewicz K
Arch Immunol Ther Exp (Warsz); 1984; 32(4):467-79. PubMed ID: 6442852
[TBL] [Abstract][Full Text] [Related]
40. Scavenging by alginate of free radicals released by macrophages.
Simpson JA; Smith SE; Dean RT
Free Radic Biol Med; 1989; 6(4):347-53. PubMed ID: 2540067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
